anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Table

Component collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 60,568
Current window 14,071-14,100
Pages 2,019
Rows per page 30
Component: Tableclear collectionreset all
18 30 60

Component

14,071-14,100 of 60,568

filter-aware
06
The slide highlights the catalyst of the conversion and provides a table of potential passive fund demand by index.Calumet+Inc.+Carbonomics+Investor+Presentation+Final+11+Nov.+'24 · Calumet
Consulting deck Equity research Beat · ProblemLoop · Cost Of Inaction1 hit
08
Calumet+Inc.+Carbonomics+Investor+Presentation+Final+11+Nov.+'24Calumet+Inc.+Carbonomics+Investor+Presentation+Final+11+Nov.+'24 · Calumet
Consulting deck Equity research Beat · SolutionLoop · Cost Of Inaction1 hit
09
Includes a table detailing estimated yields in kbcd for Renewable Diesel, Jet, and Naphtha across three time horizons.Calumet+Inc.+Carbonomics+Investor+Presentation+Final+11+Nov.+'24 · Calumet
Consulting deck Equity research Loop · Cost Of Inaction1 hit
14
The slide uses a bar chart to show production capacity relative to competitors and a map to show brand distribution from the central Louisiana hub.Calumet+Inc.+Carbonomics+Investor+Presentation+Final+11+Nov.+'24 · Calumet
Consulting deck Equity research Beat · Product1 hit
15
Includes a data table for annual/quarterly financials and two charts (bar and dual-axis line) for operational metrics.Calumet+Inc.+Carbonomics+Investor+Presentation+Final+11+Nov.+'24 · Calumet
Consulting deck Equity research Beat · Product1 hit
16
Calumet+Inc.+Carbonomics+Investor+Presentation+Final+11+Nov.+'24Calumet+Inc.+Carbonomics+Investor+Presentation+Final+11+Nov.+'24 · Calumet
Consulting deck Equity research Beat · Product1 hit
20
Includes a table of financial and production data alongside qualitative bullet points for two business units.Calumet+Inc.+Carbonomics+Investor+Presentation+Final+11+Nov.+'24 · Calumet
Consulting deck Equity research Loop · Why Now1 hit
23
Calumet+Inc.+Carbonomics+Investor+Presentation+Final+11+Nov.+'24Calumet+Inc.+Carbonomics+Investor+Presentation+Final+11+Nov.+'24 · Calumet
Consulting deck Equity research Beat · Team1 hit
26
The table tracks debt components, total debt, net recourse debt, stockholders' equity, and leverage ratios (Net Recourse Debt / LTM Adjusted EBITDA).Calumet+Inc.+Carbonomics+Investor+Presentation+Final+11+Nov.+'24 · Calumet
Consulting deck Equity research Beat · Team1 hit
27
Standard financial reconciliation table showing adjustments for depreciation, interest, and various non-recurring items.Calumet+Inc.+Carbonomics+Investor+Presentation+Final+11+Nov.+'24 · Calumet
Consulting deck Equity research 1 hit
28
Includes both absolute dollar values and per-barrel metrics, plus EBITDA reconciliation.Calumet+Inc.+Carbonomics+Investor+Presentation+Final+11+Nov.+'24 · Calumet
Consulting deck Equity research 1 hit
45
Includes a timeline of the conversion process and a specific calculation of the IFRS measurement effect.Fresenius SE 2023 06 13 14 Goldman Sachs 44th Annual Global Healthcare Conference · Fresenius
Consulting deck Equity research 1 hit
46
The table breaks down revenue by MedTech, Nutrition, Biopharma (grouped as Growth Vectors), and Pharma (IV Drugs & Fluids).Fresenius SE 2023 06 13 14 Goldman Sachs 44th Annual Global Healthcare Conference · Fresenius
Consulting deck Equity research 1 hit
47
The table displays financial metrics including EBITDA, EBIT, and margins for Total, Growth Vectors, Pharma, and Corporate segments.Fresenius SE 2023 06 13 14 Goldman Sachs 44th Annual Global Healthcare Conference · Fresenius
Consulting deck Equity research 1 hit
48
The table includes organic growth figures and margin changes in basis points.Fresenius SE 2023 06 13 14 Goldman Sachs 44th Annual Global Healthcare Conference · Fresenius
Consulting deck Equity research 1 hit
49
Fresenius SE 2023 06 13 14 Goldman Sachs 44th Annual Global Healthcare ConferenceFresenius SE 2023 06 13 14 Goldman Sachs 44th Annual Global Healthcare Conference · Fresenius
Consulting deck Equity research 1 hit
50
Fresenius SE 2023 06 13 14 Goldman Sachs 44th Annual Global Healthcare ConferenceFresenius SE 2023 06 13 14 Goldman Sachs 44th Annual Global Healthcare Conference · Fresenius
Consulting deck Equity research 1 hit
51
Includes specific breakdowns for Fresenius Medical Care, Kabi, Helios, and Vamed.Fresenius SE 2023 06 13 14 Goldman Sachs 44th Annual Global Healthcare Conference · Fresenius
Consulting deck Equity research 1 hit
52
Fresenius SE 2023 06 13 14 Goldman Sachs 44th Annual Global Healthcare ConferenceFresenius SE 2023 06 13 14 Goldman Sachs 44th Annual Global Healthcare Conference · Fresenius
Consulting deck Equity research 1 hit
53
Fresenius SE 2023 06 13 14 Goldman Sachs 44th Annual Global Healthcare ConferenceFresenius SE 2023 06 13 14 Goldman Sachs 44th Annual Global Healthcare Conference · Fresenius
Consulting deck Equity research 1 hit
54
Includes margins for each metric. Data is in €m.Fresenius SE 2023 06 13 14 Goldman Sachs 44th Annual Global Healthcare Conference · Fresenius
Consulting deck Equity research 1 hit
55
Includes margins for each cash flow metric. Data is in €m.Fresenius SE 2023 06 13 14 Goldman Sachs 44th Annual Global Healthcare Conference · Fresenius
Consulting deck Equity research 1 hit
56
Fresenius SE 2023 06 13 14 Goldman Sachs 44th Annual Global Healthcare ConferenceFresenius SE 2023 06 13 14 Goldman Sachs 44th Annual Global Healthcare Conference · Fresenius
Consulting deck Equity research 1 hit
02
This is a standard investment strategy fact sheet/profile.gol 6 · Morgan Stanley
Consulting deck Equity research 1 hit
06
The slide discusses the limitations of CAPM and introduces a six-factor model as a more robust alternative for strategic asset allocation.Goldman Sachs Ayco Outlook 2024 Webinar Materials · Goldman Sachs
Consulting deck Equity research Beat · Solution & ApproachLoop · Zoom In1 hit
10
The chart illustrates the impact of leverage and factor-based diversification on portfolio performance.Goldman Sachs Ayco Outlook 2024 Webinar Materials · Goldman Sachs
Consulting deck Equity research Beat · Impact & Next StepsLoop · Mece Breakdown1 hit
09
The table uses color coding (blue vs grey) to indicate which companies are STRATEC customers.GOLDMAN SACHS MEDTECH AND HEALTHCARE SERVICES CONFERENCE · Stratec
Consulting deck Equity research 1 hit
12
Includes adjustments for amortization and non-recurring items as per footnote.GOLDMAN SACHS MEDTECH AND HEALTHCARE SERVICES CONFERENCE · Stratec
Consulting deck Equity research Beat · FinancialsLoop · Cost Of Inaction1 hit
20
Figures are adjusted for comparison, including depreciation/amortization from PPA, integration expenses, and other extraordinary effects.GOLDMAN SACHS MEDTECH AND HEALTHCARE SERVICES CONFERENCE · Stratec
Consulting deck Equity research 1 hit
22
Includes pie chart of ownership split and list of institutional investors > 3%.GOLDMAN SACHS MEDTECH AND HEALTHCARE SERVICES CONFERENCE · Stratec
Consulting deck Equity research 1 hit